Roche is awarded IDC Best in Future of Intelligence award for implementing data mesh strategy at scale with Immuta 

Roche is awarded IDC Best in Future of Intelligence award for implementing data mesh strategy at scale with Immuta 

Roche, one of the world’s largest pharmaceutical companies, was awarded IDC’s Future Enterprise Best in Future of Intelligence EMEA Award for its enterprise self-service data platform, which uses Immuta for data protection and fine-grained access control at both a central and domain level. IDC is a premier global provider of market intelligence and advisory services, and the award recognises organisations on the leading edge of innovation, digital transformation and operation excellence. In its inaugural year, the program received submissions spanning over 15 industries and over 600 organisations. 

The award recognises Roche for their data platform transformation that has enabled them to build over 200 new data products, resulting in over US$50 million in benefits. The 125-year-old multinational worked with Immuta and other vendors to successfully build an enterprise-wide data mesh at scale. They moved away from relying on a central IT team solely responsible for data requests and implemented decentralised data ownership across multiple domains of the business in 90 countries across the world. With this new approach they could launch new data products more quickly and give users fast self-service access to data.  

The IDC Future Enterprise Best in Future of Intelligence EMEA Award recognises organisations that are innovating around how they synthesise information, and recognised Roche’s data mesh strategy as a stand-out example of delivering insights at scale and developing and promoting a data culture.  

Pierre Alexandre Fischer, Global Informatics, Data Platform Product Line Lead at Roche said: “Our digital transformation strategy supports our wider business objectives of building transformative, innovative cross functional data products and data sharing solutions across the company value chain, and to deliver on our commitments to our people, partners, stakeholders and, most importantly, the patients we serve.” 

Click below to share this article